1.Berenholtz, SM, Pronovost, PJ, Lisett, PA, et al.Eliminating catheter-related bloodstream infection in the intensive care unit. Crit Care Med 2004;32:2014–2020.
2.Pronovost, P, Needham, D, Berenholtz, S, et al.An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725–2732.
3.Crnich, CJ, Maki, DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. Clin Infect Dis 2002;34:1362–1368.
4.Crnich, CJ, Maki, DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis 2002;34:1232–1242.
5.Timsit, JF, Schwebel, C, Bouadma, L, et al.Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 2009;301:1231–1241.
6.Graves, N. Economics and preventing hospital-acquired infection. Emerg Infect Dis 2004;10:561–566.
7.Perencevich, EN, Stone, PW, Wright, SB, Carmeli, Y, Fisman, DN, Cosgrove, SE. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol 2007;28:1121–1133.
8.Crnich, CJ, Maki, DG. Intravascular device infection. In: Carrico, R, Adam, L, Aureden, K, Fauerbach, L, Friedman, C, eds. APIC Text of Infection Control and Epidemiology. 3rd ed. Washington, DC: Association for Professionals in Infection Control and Epidemiology, 2009:24.1–24.2.
9.Halton, KA, Cook, DA, Whitby, M, Paterson, DL, Graves, N. Cost-effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision. Crit Care 2009;13:R35.
10.Schulgen, G, Kropec, A, Kappstein, I, Daschner, F, Schumacher, M. Estimation of extra hospital stay attributable to nosocomial infections: heterogeneity and timing of events. J Clin Epidemiol 2000;53:409–417.
11.Graves, N, Weinhold, D, Tong, E, et al.Effect of healthcare-acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol 2007;28:280–292.
12.Wolkewitz, M, Vonberg, RP, Grundmann, H, et al.Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models. Crit Care 2008;12:R44.
13.Samore, M, Shen, S, Greene, T, et al.A simulation-based evaluation of methods to estimate the impact of an adverse event on hospital length of stay. Med Care 2007;45:S108–S115.
14.Barnett, AG, Graves, N, Rosenthal, VD, Salomao, R, Rangel-Frausto, MS. Excess length of stay due to central line-associated bloodstream infection in intensive care units in Argentina, Brazil, and Mexico. Infect Control Hosp Epidemiol 2010;31(11):1106–1114 (in this issue).
15.Beyersmann, J, Gastmeier, P, Grundmann, H, et al.Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol 2006;27:493–499.
16.Soufir, L, Timsit, JF, Mahe, C, Carlet, J, Regnier, B, Chevret, S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999;20:396–401.